Testing a supplement for menstrual pain relief
Part of Women’s health & pregnancy clinical trials.
This study tests a supplement called CL22205 to see if it can reduce menstrual pain and improve quality of life for women with longer cycles and monthly discomfort. If you have period pain that bothers you and your cycle is between 36 and 45 days, this may be an option to explore.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 25 and 35 years old.
- Your menstrual cycle is usually between 36 and 45 days (longer than typical but not too long).
- You have had moderate to severe menstrual pain for at least the last two periods.
- You do not smoke and do not drink alcohol.
- You have a normal thyroid (checked by a blood test) and are generally healthy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called CL25216 can reduce severe menstrual cramps and help balance hormones in women. If you experience moderate to severe period pain, this trial might help you find relief.
This trial tests if a supplement called CL22205 can improve bone density and reduce menopause symptoms. It may help women who have low bone mass (osteopenia) and are experiencing common menopausal issues like sleep problems, mood changes, or fatigue.
This trial tests a device that gently stimulates a nerve in your ear to see if it eases menstrual cramps. It may offer a drug-free option for managing period pain.
This trial tests two supplements (Elix Cycle Balance and Elix Daily Harmony) to see if they can reduce pain and other symptoms caused by uterine fibroids. It is for women who have regular but painful periods and want to try a non-medicine option.
This study tests a product called Effera to see if it helps reduce menstrual cramps, pain, and premenstrual symptoms like mood changes and bloating. You'll track your symptoms and complete online surveys over several weeks.
This Phase 3 study tests whether CDE100 can reduce menstrual cramp pain in people with primary dysmenorrhea (cramps that are not caused by another medical condition). It also checks how safe the treatment is and how it’s tolerated over time.
Hear when a new Menstrual Discomfort trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.